content

High Barrier Containers Meet New Standards in Healthcare Packaging

Today, the chief purpose of primary packaging is product protection. However this performance capability has become more challenging in recent years as the complexity...

Establishing a high throughput screen of drug solubility in pharmaceutical excipients

At the discovery and early stages of drug development, the aim is to evaluate the pharmacology, pharmacokinetics and toxicology of a compound using a...

A Scapegoat for Site Payment Challenges

Managing site payments is not an easy task. They are frustrating, burdensome and a drain of time and resources. CROs, specifically project managers, are...

Overcoming the challenges of clinical trial recruitment using big data technologies

The problem defined: Any prospective new drug must successfully pass a succession of three clinical trials phases, before it can apply for market approval. TheseΒ trials...

Cell based therapy and FDA review: Partnering for success at your pre-IND meeting

Regenerative and cell-based therapies have only recently begun to deliver on the promise they have portended for years, creating opportunities to positively impact patient...

Recipharm opens new GMP suite for clinical trial material

Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility...

Bristol-Myers NASH Drug Reduces Liver Fat In Midstage Study

Bristol-Myers Squibb Company announced data from a Phase 2 study of BMS-986036, an investigational pegylated analogue of human fibroblast growth factor 21 (FGF21), a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read